Cargando…

Endocrine dysfunction in patients of leprosy

BACKGROUND: Leprosy is a chronic granulomatous disease and affects many internal organs in addition to the skin and peripheral nerves. Endocrine dysfunction is often silent and is often missed in patients of leprosy leading to significant morbidity. We studied the presence of occult endocrine disord...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Rohit Kumar, Bhasin, Rohit, Bisht, Y. S., Kumar, K. V. S. Hari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366775/
https://www.ncbi.nlm.nih.gov/pubmed/25932392
http://dx.doi.org/10.4103/2230-8210.152775
_version_ 1782362418888835072
author Singh, Rohit Kumar
Bhasin, Rohit
Bisht, Y. S.
Kumar, K. V. S. Hari
author_facet Singh, Rohit Kumar
Bhasin, Rohit
Bisht, Y. S.
Kumar, K. V. S. Hari
author_sort Singh, Rohit Kumar
collection PubMed
description BACKGROUND: Leprosy is a chronic granulomatous disease and affects many internal organs in addition to the skin and peripheral nerves. Endocrine dysfunction is often silent and is often missed in patients of leprosy leading to significant morbidity. We studied the presence of occult endocrine disorders in leprosy patients and compared the same with disease parameters. MATERIALS AND METHODS: We evaluated 40 patients of leprosy (aged 18–70 years, any duration) in this cross-sectional, observational study. All subjects were assessed for pituitary, thyroid, adrenal, gonadal function, and dynamic testing was done when deemed necessary. The participants were divided into two groups: Group 1 (Leprosy, n = 40) and Group 2 (Controls, n = 20) and the data were analyzed with appropriate statistical tests. RESULTS: The study participants (35 males, 5 females) had a mean age of 36.4 ± 11.3 years, and duration of the disease was 2.5 ± 5.5 years. Eleven out of 40 patients showed results consistent with an endocrine disorder, including subclinical hypothyroidism (n = 4), sick euthyroid syndrome (n = 3), growth hormone (GH) deficiency (n = 2), primary hypogonadism (n = 2) and secondary hypogonadism in one patient. One patient had partial hypopituitarism (GH deficiency and secondary hypogonadism) and none of the controls showed any hormonal dysfunction. Testosterone levels showed inverse correlation with the number of skin patches (P = 0.0006). CONCLUSION: Occult endocrine dysfunction is seen in a quarter of patients with leprosy. Thyroid and gonadal axes abnormalities are common, and the severity is more in lepromatous forms of the disease. Further large studies are required to confirm the findings observed in our study.
format Online
Article
Text
id pubmed-4366775
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-43667752015-05-01 Endocrine dysfunction in patients of leprosy Singh, Rohit Kumar Bhasin, Rohit Bisht, Y. S. Kumar, K. V. S. Hari Indian J Endocrinol Metab Original Article BACKGROUND: Leprosy is a chronic granulomatous disease and affects many internal organs in addition to the skin and peripheral nerves. Endocrine dysfunction is often silent and is often missed in patients of leprosy leading to significant morbidity. We studied the presence of occult endocrine disorders in leprosy patients and compared the same with disease parameters. MATERIALS AND METHODS: We evaluated 40 patients of leprosy (aged 18–70 years, any duration) in this cross-sectional, observational study. All subjects were assessed for pituitary, thyroid, adrenal, gonadal function, and dynamic testing was done when deemed necessary. The participants were divided into two groups: Group 1 (Leprosy, n = 40) and Group 2 (Controls, n = 20) and the data were analyzed with appropriate statistical tests. RESULTS: The study participants (35 males, 5 females) had a mean age of 36.4 ± 11.3 years, and duration of the disease was 2.5 ± 5.5 years. Eleven out of 40 patients showed results consistent with an endocrine disorder, including subclinical hypothyroidism (n = 4), sick euthyroid syndrome (n = 3), growth hormone (GH) deficiency (n = 2), primary hypogonadism (n = 2) and secondary hypogonadism in one patient. One patient had partial hypopituitarism (GH deficiency and secondary hypogonadism) and none of the controls showed any hormonal dysfunction. Testosterone levels showed inverse correlation with the number of skin patches (P = 0.0006). CONCLUSION: Occult endocrine dysfunction is seen in a quarter of patients with leprosy. Thyroid and gonadal axes abnormalities are common, and the severity is more in lepromatous forms of the disease. Further large studies are required to confirm the findings observed in our study. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4366775/ /pubmed/25932392 http://dx.doi.org/10.4103/2230-8210.152775 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Singh, Rohit Kumar
Bhasin, Rohit
Bisht, Y. S.
Kumar, K. V. S. Hari
Endocrine dysfunction in patients of leprosy
title Endocrine dysfunction in patients of leprosy
title_full Endocrine dysfunction in patients of leprosy
title_fullStr Endocrine dysfunction in patients of leprosy
title_full_unstemmed Endocrine dysfunction in patients of leprosy
title_short Endocrine dysfunction in patients of leprosy
title_sort endocrine dysfunction in patients of leprosy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366775/
https://www.ncbi.nlm.nih.gov/pubmed/25932392
http://dx.doi.org/10.4103/2230-8210.152775
work_keys_str_mv AT singhrohitkumar endocrinedysfunctioninpatientsofleprosy
AT bhasinrohit endocrinedysfunctioninpatientsofleprosy
AT bishtys endocrinedysfunctioninpatientsofleprosy
AT kumarkvshari endocrinedysfunctioninpatientsofleprosy